| PALVELLA THERAPEUTICS NEW |
| USA |
| Gesundheit |
| US6979471090 / A40RA6 |
| PI6 (Frankfurt) / PVLA (NASDAQ) |
| FRA:PI6, ETR:PI6, PI6:GR, NASDAQ:PVLA |
| - |
| https://palvellatx.com/ |
|
Palvella Therapeutics Inc is a pharmaceutical company committed to the development of therapies for rare and serious dermatologic conditions. Its primary focus lies in creating innovative treatments that address unmet medical needs in the dermatology..
>Volltext.. |
| 1414.1 Mio. EUR |
| 1187.73 Mio. EUR |
| - |
| - |
| -42.97 Mio. EUR |
| -3.63 EUR |
| - |
| 179.92 Mio. EUR |
| - |
| 28.73 |
| -100% |
| -183.28% |
| - |
| - |
| - |
| PALVELLA |
| 23.06.26 |
|
||||
|